A.I. Cancer Drugmaker Meeting with Big Pharma Companies

BERG is a biotech company that creates cancer drugs through A.I. and machine learning. Based on recent FDA meetings and discussions, BERG has two drug products moving towards Phase 3 development and other late stage assets in planning phases. Niven Narain, co-founder and CEO of BERG, joined Cheddar to discuss.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.